EC8 Stock Overview
A medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
CONMED Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$66.50 |
| 52 Week High | US$104.00 |
| 52 Week Low | US$56.00 |
| Beta | 1.46 |
| 11 Month Change | 12.71% |
| 3 Month Change | 9.92% |
| 1 Year Change | -32.49% |
| 33 Year Change | -46.80% |
| 5 Year Change | -34.16% |
| Change since IPO | 337.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| EC8 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.6% | -3.4% | -0.2% |
| 1Y | -32.5% | -4.3% | 8.3% |
Return vs Industry: EC8 underperformed the German Medical Equipment industry which returned -3.2% over the past year.
Return vs Market: EC8 underperformed the German Market which returned 9.6% over the past year.
Price Volatility
| EC8 volatility | |
|---|---|
| EC8 Average Weekly Movement | 5.5% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EC8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: EC8's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 4,000 | Curt Hartman | www.conmed.com |
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.
CONMED Corporation Fundamentals Summary
| EC8 fundamental statistics | |
|---|---|
| Market cap | €2.09b |
| Earnings (TTM) | €125.14m |
| Revenue (TTM) | €1.22b |
16.9x
P/E Ratio1.7x
P/S RatioIs EC8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EC8 income statement (TTM) | |
|---|---|
| Revenue | US$1.29b |
| Cost of Revenue | US$569.15m |
| Gross Profit | US$718.96m |
| Other Expenses | US$587.22m |
| Earnings | US$131.74m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.26 |
| Gross Margin | 55.82% |
| Net Profit Margin | 10.23% |
| Debt/Equity Ratio | 100.6% |
How did EC8 perform over the long term?
See historical performance and comparison